ReviewFrontiers in immunology2022

Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives.

Jan Miroslav Hartinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.